Cargando…
Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer
SIMPLE SUMMARY: We generated a platform for designing optimized functional therapeutic antibodies against cancer glycans. The target tumor-associated carbohydrate antigen is commonly expressed in colon and pancreatic cancers. We developed a system for selection of potent antibodies by yeast surface...
Autores principales: | Amon, Ron, Rosenfeld, Ronit, Perlmutter, Shahar, Grant, Oliver C., Yehuda, Sharon, Borenstein-Katz, Aliza, Alcalay, Ron, Marshanski, Tal, Yu, Hai, Diskin, Ron, Woods, Robert J., Chen, Xi, Padler-Karavani, Vered |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601599/ https://www.ncbi.nlm.nih.gov/pubmed/33007970 http://dx.doi.org/10.3390/cancers12102824 |
Ejemplares similares
-
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2020) -
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
por: Yehuda, Sharon, et al.
Publicado: (2020) -
A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen
por: Amon, Ron, et al.
Publicado: (2018) -
Evolution of sialic acids: Implications in xenotransplant biology
por: Paul, Anu, et al.
Publicado: (2018) -
Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States
por: Soulillou, Jean-Paul, et al.
Publicado: (2020)